Skip to main content
SpringerLink
Log in

Liver Cirrhosis

  • Chapter
Clinical Hepatology

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Angeli P, Wong F, Watson H, et al (2006) Hyponatremia in cirrhosis: results of a patients population survey. Hepatology 44: 1535–42

    Article  CAS  PubMed  Google Scholar 

  2. Anthony PP, Ishak KG, Nayak NC, et al (1977) The morphology of cirrhosis: definition, nomenclature and classification. Bull World Health Organ 55: 521–40

    CAS  PubMed  Google Scholar 

  3. Anthony PP, Ishak KG, Nayak NC, et al (1978) The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol 31: 395–414

    Article  CAS  PubMed  Google Scholar 

  4. Benvegnù L, Gios M, Boccato S, et al (2004) Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 53: 744–9

    Article  PubMed  Google Scholar 

  5. Biggins SW, Rodriguez HJ, Bacchetti P, et al (2005) Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 41: 32–9

    Article  CAS  PubMed  Google Scholar 

  6. Bosetti C, Levi F, Lucchini F, et al (2007) Worldwide mortality from cirrhosis: an update to 2002. J Hepatol 46: 827–39

    Article  PubMed  Google Scholar 

  7. Botta F, Giannini E, Romagnoli P, et al (2003) MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 52: 134–9

    Article  CAS  PubMed  Google Scholar 

  8. Browning JD, Kumar KS, Saboorian MH, et al (2004) Ethnic differences in the prevalence of cryptogenic cirrhosis. Am J Gastroenterol 99: 292–8

    Article  PubMed  Google Scholar 

  9. Butt AK, Khan AA, Alam A, et al (1998) Predicting hospital mortality in cirrhotic patients: comparison of Child—Pugh and acute physiology, age and chronic health evaluation (APACHE III) scoring systems. Am J Gastroenterol 93: 2469–75

    Article  CAS  PubMed  Google Scholar 

  10. Byrnes V, Shi H, Kiryu S, et al (2007) The clinical outcome of small (< 20 mm) arterially enhancing nodules on MRI in the cirrhotic liver. Am J Gastroenterol 102: 1654–9

    Article  PubMed  Google Scholar 

  11. Calle EE, Rodriguez C, Walker-Thurmond K, et al (2003) Overweight, obesity, and mortality from cancer in a prospec-tively studied cohort of U.S. adults. N Engl J Med 348: 1625–38

    Article  PubMed  Google Scholar 

  12. Collier J, Sherman M (1998) Screening for hepatocellular carcinoma. Hepatology 27: 273–8

    Article  CAS  PubMed  Google Scholar 

  13. Cordoba J, Cabrera J, Lataif L, et al (1998) High prevalence of sleep disturbance in cirrhosis. Hepatology 27: 339–45

    Article  CAS  PubMed  Google Scholar 

  14. D'Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44: 217–31

    Article  PubMed  Google Scholar 

  15. Delhaye M, Louis H, Degraef C, et al (1999) Hepatocyte pro-liferative activity in human liver cirrhosis. J Hepatol 30: 461–71

    Article  CAS  PubMed  Google Scholar 

  16. Desmet VJ, Roskams T (2004) Cirrhosis reversal: a duel between dogma and myth. J Hepatol 40: 860–7

    Article  PubMed  Google Scholar 

  17. Dufour JF, De Lellis R, Kaplan MM (1997) Reversibility of hepatic fibrosisin autoimmune hepatitis. Ann Int Med 127: 981–5

    CAS  PubMed  Google Scholar 

  18. Dufour JF, De Lellis R, Kaplan MM (1998) Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment. Dig Dis Sci 43: 2573–6

    Article  CAS  PubMed  Google Scholar 

  19. El-Serag HB, Tran T, Everhart JE (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126: 460–8

    Article  PubMed  Google Scholar 

  20. Fifth Pan American Congress of Gastroenterology, Report of the Board for Classification and Nomenclature of Cirrhosis of the Liver (1956) Gastroenterology 31: 213–9

    Google Scholar 

  21. Figueiredo FA, De Mello Perez R, Kondo M, et al (2005) Effect of liver cirrhosis on body composition: evidence of significant depletion even in mild disease. J Gastroenterol Hepatol 20: 209–16

    Article  PubMed  Google Scholar 

  22. Friedman SL (2000) Molecular regulation of hepatic fibro-sis, an integrated cellular response to tissue injury. J Biol Chem 275: 2247–50

    Article  CAS  PubMed  Google Scholar 

  23. Friedman SL, Arthur MJ (2002) Reversing hepatic fibrosis. Sci Med 8: 194–205

    CAS  Google Scholar 

  24. Friedrich-Rust M, Ong MF, Martens S, et al (2008) Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134: 960–74

    Article  PubMed  Google Scholar 

  25. Greeve M, Ferrell L, Kim M, et al (1993) Cirrhosis of unde-fined pathogenesis: absence of evidence for unknown viruses or autoimmune processes. Hepatology 17: 593–98

    Article  CAS  PubMed  Google Scholar 

  26. Gunsar F, Raimondo ML, Jones S, et al (2006) Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther 24: 563–72

    Article  CAS  PubMed  Google Scholar 

  27. Habib A, Mihas AA, Abou-Assi SG, et al (2005) High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics. Clin Gastroenterol Hepatol 3: 286–91

    Article  CAS  PubMed  Google Scholar 

  28. Hällen J, Nord J (1965) Liver cirrhosis unsuspected during life: a series of 79 cases. J Chron Dis 17: 951–8

    Article  Google Scholar 

  29. Huo TI, Wu JC, Lin HC, et al (2005) Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J Hepatol 42: 826–32

    Article  PubMed  Google Scholar 

  30. Huo TI, Lin HC, Lee F Y, et al (2006) Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score. Liver Int 26: 55–61

    Article  PubMed  Google Scholar 

  31. Ioannou GN, Splan MF, Weiss NS, et al (2007) Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 5: 938–45

    Article  PubMed  Google Scholar 

  32. Kamath PS, Wiesner RH, Malinchoc M, et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33: 464–70

    Article  CAS  PubMed  Google Scholar 

  33. Klatsky AL, Morton C, Udaltsova N, et al (2006) Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 166: 1190–5

    Article  PubMed  Google Scholar 

  34. Libbrecht L, Cassiman D, Verslype C, et al (2006) Clinico-pathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers. Am J Gastroenterol 101: 2341–6

    Article  PubMed  Google Scholar 

  35. Lichtinghagen R, Breitenstein K, Arndt B, et al (1998) Comparison of matrix metalloproteinase expression in normal and cirrhotic liver. Virchows Arch 432: 153–58

    Article  CAS  PubMed  Google Scholar 

  36. Londoño MC, Cárdenas A, Guevara M, et al (2007) MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut 56: 1283–90

    Article  PubMed  Google Scholar 

  37. Ludwig J, Hashimoto E, Porayko MK, et al (1997) Hemo-siderosis in cirrhosis. A study of 447 native livers. Gastroenterology 112: 882–88

    Article  CAS  PubMed  Google Scholar 

  38. Madden AM, Bradbury W, Morgan MY (1997) Taste perception in cirrhosis: its relationship to circulating micronu-trients and food preferences. Hepatology 26: 40–8

    Article  CAS  PubMed  Google Scholar 

  39. Maharaj B, Maharaj RJ, Leary WP, et al (1986) Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet i: 523–25

    Article  Google Scholar 

  40. Muto Y, Sato, S, Watanabe A, et al (2005) Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 3: 705–13

    Article  CAS  PubMed  Google Scholar 

  41. Nagai H, Terada Y, Tajiri T, et al (2004) Characterization of liver-cirrhosis nodules by analysis of gene-expression pro-files and patterns of allelic loss. J Hum Genet 49: 246–55

    Article  CAS  PubMed  Google Scholar 

  42. Nair S, Mason A, Eason J, et al (2002) Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 36: 150–5

    Article  PubMed  Google Scholar 

  43. Nishida T, Tsuji S, Tsujii M, et al (2006) Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol 101: 70–5

    Article  PubMed  Google Scholar 

  44. Pagliaro L, Rinaldi F, Craxi A, et al (1983) Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial. Dig Dis Sci 28: 39–43

    Article  CAS  PubMed  Google Scholar 

  45. Pateron D, Ganne N, Trinchet JC, et al (1994) Prospective study of screening for hepatocellular carcinoma in caucasian patients with cirrhosis. J Hepatol 20: 65–71

    Article  CAS  PubMed  Google Scholar 

  46. Planas R, Montoliu S, Balleste B, et al (2006) Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol 4: 1385–94

    Article  PubMed  Google Scholar 

  47. Rebouissou S, Couchy G, Libbrecht L, et al (2008) The β-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J Hepatol 49: 61–71

    Article  CAS  PubMed  Google Scholar 

  48. Roberts SE, Goldacre MJ, Yeates D (2005) Trends in mortality after hospital admission for liver cirrhosis in an English population from 1968 to 1999. Gut 54: 1615–21

    Article  CAS  PubMed  Google Scholar 

  49. Ruhl CE, Everhart JE (2005) Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 129: 1928–36

    Article  PubMed  Google Scholar 

  50. Said A, Williams J, Holden J, et al (2004) Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 40: 897–903

    Article  PubMed  Google Scholar 

  51. Sangiovanni A, Prati GM, Fasani P, et al (2006) The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients. Hepatology 43: 1303–10

    Article  PubMed  Google Scholar 

  52. Scheuer PJ (1970) Liver biopsy in the diagnosis of cirrhosis. Gut 11: 275–78

    Article  CAS  PubMed  Google Scholar 

  53. Sciot R, Staessen D, van Damme B, et al (1988) Incomplete septal cirrhosis: histopathological aspects. Histopathology 13: 593–603

    Article  CAS  PubMed  Google Scholar 

  54. Soloway RD, Baggenstoss AH, Schoenfield LJ, et al (1971) Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Dig Dis Sci 16: 1082–86

    Article  CAS  Google Scholar 

  55. Tanner MS, Portmann B (1981) Indian childhood cirrhosis. Arch Dis Childh 56: 4–6

    Article  CAS  PubMed  Google Scholar 

  56. Veldt BJ, Chen W, Heatcote EJ, et al (2008) Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 47: 1856–62

    Article  PubMed  Google Scholar 

  57. Wanless IR, Nakashima E, Sherman M (2000) Regression of human cirrhosis: morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 124: 1599–607

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chair, Department of Medicine II, Klinikum Offenbach, Goethe University Frankfurt/Main, Starkenburgring 66, Offenbach, 63069, Germany

    Henryk Dancygier (Professor of Medicine)

  2. Department of Medicine, Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, USA

    Henryk Dancygier (Professor of Medicine)

Authors
  1. Henryk Dancygier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dancygier, H. (2010). Liver Cirrhosis. In: Clinical Hepatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04519-6_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-04519-6_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-04509-7

  • Online ISBN: 978-3-642-04519-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation